Variant report

Variant	nsv962260
Chromosome Location	chr17:15428362-15439978
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr17:15428817-15428915	A549	lung:	n/a	n/a
2	CEBPB	chr17:15428777-15428979	K562	blood:	n/a	n/a
3	CEBPB	chr17:15429971-15430065	Hela-S3	cervix:	n/a	n/a
4	CEBPB	chr17:15428680-15428987	K562	blood:	n/a	n/a
5	CEBPB	chr17:15428722-15429000	IMR90	lung:	n/a	n/a
6	CEBPD	chr17:15430138-15430536	K562	blood:	n/a	n/a
7	CTCF	chr17:15429960-15430110	NHDF-neo	bronchial:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
8	CTCF	chr17:15429980-15430130	Caco-2	colon:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
9	CTCF	chr17:15430000-15430150	GM12865	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
10	CTCF	chr17:15429980-15430130	HL-60	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
11	CTCF	chr17:15429940-15430090	MCF-7	breast:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
12	CTCF	chr17:15429920-15430070	Caco-2	colon:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
13	CTCF	chr17:15429891-15430142	Hela-S3	cervix:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
14	CTCF	chr17:15429980-15430130	SK-N-SH_RA	brain:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
15	CTCF	chr17:15429960-15430110	GM12870	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
16	CTCF	chr17:15430000-15430150	GM12872	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
17	CTCF	chr17:15429720-15429870	HCT-116	colon:	n/a	n/a
18	CTCF	chr17:15430000-15430150	HEEpiC	esophagus:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
19	CTCF	chr17:15429920-15430070	GM12865	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
20	CTCF	chr17:15429909-15430177	Pancreas_OC	pancreas:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
21	CTCF	chr17:15429886-15430125	H1-hESC	embryonic stem cell:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
22	CTCF	chr17:15429863-15430144	GM13976	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
23	CTCF	chr17:15429812-15430232	IMR90	lung:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
24	CTCF	chr17:15429853-15430185	K562	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
25	CTCF	chr17:15429940-15430090	HFF	foreskin:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
26	CTCF	chr17:15432133-15432184	Fibrobl	skin:	n/a	n/a
27	CTCF	chr17:15429980-15430130	HEEpiC	esophagus:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
28	CTCF	chr17:15429931-15430151	LNCaP	prostate:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
29	CTCF	chr17:15429940-15430090	NB4	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
30	CTCF	chr17:15430000-15430150	NHEK	skin:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
31	CTCF	chr17:15429940-15430090	GM12867	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
32	CTCF	chr17:15429960-15430110	NHLF	lung:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
33	CTCF	chr17:15430040-15430190	NHDF-neo	bronchial:	n/a	n/a
34	CTCF	chr17:15429989-15430100	GM19240	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
35	CTCF	chr17:15429667-15430395	SK-N-SH	brain:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
36	CTCF	chr17:15429980-15430130	Hela-S3	cervix:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
37	CTCF	chr17:15429960-15430110	GM12869	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
38	CTCF	chr17:15429699-15430293	A549	lung:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
39	CTCF	chr17:15429980-15430130	GM12874	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
40	CTCF	chr17:15429954-15430135	ECC-1	luminal epithelium:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
41	CTCF	chr17:15430000-15430150	GM06990	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
42	CTCF	chr17:15429980-15430130	K562	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
43	CTCF	chr17:15429931-15430143	GM13977	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
44	CTCF	chr17:15429700-15429850	A549	lung:	n/a	n/a
45	CTCF	chr17:15429680-15429830	HVMF	connective:	n/a	n/a
46	CTCF	chr17:15429980-15430130	HPAF	blood vessel:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
47	CTCF	chr17:15429980-15430130	AG04449	skin:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
48	CTCF	chr17:15429920-15430070	NHEK	skin:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
49	CTCF	chr17:15429940-15430090	HA-sp	spinal cord:	n/a	chr17:15430016-15430037 chr17:15430021-15430039
50	CTCF	chr17:15430001-15430069	GM19239	blood:	n/a	chr17:15430016-15430037 chr17:15430021-15430039

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AC005838.1-3	chr17:15434087-15434403	ENSG00000266538.1

Variant related genes	Relation type
ENSG00000266538	TF binding region

Extended variants
information (count: 398 )
Associated
traits (count: 129 )

Variant overlapped rSNPs/rCNVs (count:398 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs565005136	chr17:15428377-15428378	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs150593470	chr17:15428396-15428397	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs547112868	chr17:15428408-15428409	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs2589680	chr17:15428426-15428427	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs73978055	chr17:15428428-15428429	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs529741947	chr17:15428462-15428463	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs549424118	chr17:15428491-15428492	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs528134617	chr17:15428494-15428495	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs569930534	chr17:15428513-15428514	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs538820255	chr17:15428521-15428522	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs559082218	chr17:15428528-15428529	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs566275889	chr17:15428554-15428555	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs535315086	chr17:15428569-15428570	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs369108325	chr17:15428578-15428579	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs554710608	chr17:15428742-15428743	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs386795806	chr17:15428791-15428792	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs147688251	chr17:15428792-15428793	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs558746423	chr17:15428819-15428820	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs142363023	chr17:15428867-15428868	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs576326364	chr17:15428935-15428936	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs545251497	chr17:15428957-15428958	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs151117211	chr17:15428977-15428978	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	mRNA abundance
23	rs537223610	chr17:15428979-15428980	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs148381671	chr17:15428980-15428981	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs541271289	chr17:15429001-15429002	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs560729971	chr17:15429013-15429014	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs150458494	chr17:15429014-15429015	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs71367507	chr17:15429015-15429016	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs569438253	chr17:15429016-15429017	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs138445289	chr17:15429026-15429027	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs552535450	chr17:15429083-15429084	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs566257678	chr17:15429086-15429087	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs535011525	chr17:15429125-15429126	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs142951948	chr17:15429140-15429141	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs146221544	chr17:15429160-15429161	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs201067494	chr17:15429216-15429217	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs537417150	chr17:15429228-15429229	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs557371497	chr17:15429253-15429254	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs189325779	chr17:15429293-15429294	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs112556520	chr17:15429301-15429302	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs143847266	chr17:15429312-15429313	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs397834834	chr17:15429333-15429334	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs201766155	chr17:15429336-15429337	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs558520184	chr17:15429366-15429367	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs572164103	chr17:15429372-15429373	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs540982749	chr17:15429373-15429374	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs182020922	chr17:15429375-15429376	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs560820881	chr17:15429388-15429389	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs574368203	chr17:15429404-15429405	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs57993987	chr17:15429425-15429426	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:129)

Disease	PMID	Source
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	17603634	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	19435819	CNVD
Non-small cell lung cancer	19010865	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16774939	CNVD
Hepatocellular carcinoma	18803288	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Multiple myeloma	16616336	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	21509527	CNVD
Pancreatic cancer	21811587	CNVD
Autism	17322880	CNVD
Hereditary neuropathy with liability to pressure palsy	19521722	CNVD
Schizophrenia	19571808	CNVD
Schizophrenia	19955444	CNVD
Charcot-marie-tooth disease	18787571	CNVD
Breast cancer	20409316	CNVD
Autism	18414403	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Myelofibrosis	22110671	CNVD
Peripheral neuropathy	21193943	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	22958593	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	20844748	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	21858162	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	22102821	CNVD
Gastric cancer	18160780	CNVD
Non-syndromic sensorineural hearing loss	17431168	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:162 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:15383400-15455000	Weak transcription	Gastric	stomach
2	chr17:15393400-15451200	Weak transcription	Pancreatic Islets	Pancreatic Islet
3	chr17:15394800-15450800	Weak transcription	Placenta Amnion	Placenta Amnion
4	chr17:15406600-15428800	Weak transcription	Primary neutrophils fromperipheralblood	blood
5	chr17:15406800-15450600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
6	chr17:15410800-15429000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
7	chr17:15414000-15429000	Weak transcription	Fetal Heart	heart
8	chr17:15414000-15430200	Weak transcription	Right Ventricle	heart
9	chr17:15416200-15466000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
10	chr17:15417600-15466400	Weak transcription	Ovary	ovary
11	chr17:15418000-15429200	Weak transcription	Colon Smooth Muscle	Colon
12	chr17:15418400-15430000	Weak transcription	K562	blood
13	chr17:15418400-15430200	Weak transcription	Pancreas	Pancrea
14	chr17:15418600-15429600	Weak transcription	Brain Substantia Nigra	brain
15	chr17:15418600-15450600	Weak transcription	Brain Angular Gyrus	brain
16	chr17:15418800-15450600	Weak transcription	Brain Cingulate Gyrus	brain
17	chr17:15419600-15442000	Weak transcription	Cortex derived primary cultured neurospheres	brain
18	chr17:15419800-15442400	Weak transcription	Thymus	Thymus
19	chr17:15419800-15448400	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
20	chr17:15420000-15428800	Weak transcription	Primary hematopoietic stem cells	blood
21	chr17:15420000-15428800	Weak transcription	Fetal Lung	lung
22	chr17:15420000-15429600	Weak transcription	Brain Inferior Temporal Lobe	brain
23	chr17:15420000-15429800	Weak transcription	Brain Anterior Caudate	brain
24	chr17:15420000-15441800	Weak transcription	Primary T helper cells fromperipheralblood	blood
25	chr17:15420000-15442000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
26	chr17:15420000-15442000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
27	chr17:15420000-15442000	Weak transcription	A549	lung
28	chr17:15420000-15448400	Weak transcription	Placenta	Placenta
29	chr17:15420000-15450800	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
30	chr17:15420200-15428600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
31	chr17:15420200-15442000	Weak transcription	Lung	lung
32	chr17:15420200-15448600	Weak transcription	Duodenum Smooth Muscle	Duodenum
33	chr17:15420400-15429000	Weak transcription	Duodenum Mucosa	Duodenum
34	chr17:15420400-15435200	Weak transcription	HUES48 Cell Line	embryonic stem cell
35	chr17:15420400-15442000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
36	chr17:15420400-15442000	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
37	chr17:15420400-15442000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
38	chr17:15420400-15452800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
39	chr17:15420600-15435600	Weak transcription	Primary T cells fromperipheralblood	blood
40	chr17:15420600-15441800	Weak transcription	Fetal Brain Female	brain
41	chr17:15420600-15442000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
42	chr17:15420600-15459600	Weak transcription	Primary T helper cells PMA-I stimulated	--
43	chr17:15420800-15442000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
44	chr17:15420800-15448200	Weak transcription	H1 Cell Line	embryonic stem cell
45	chr17:15420800-15448400	Weak transcription	Fetal Muscle Leg	muscle
46	chr17:15420800-15448400	Weak transcription	HSMM	muscle
47	chr17:15420800-15450200	Weak transcription	Brain Germinal Matrix	brain
48	chr17:15421000-15428800	Weak transcription	Rectal Mucosa Donor 29	rectum
49	chr17:15421000-15429600	Weak transcription	Brain Hippocampus Middle	brain
50	chr17:15421200-15428800	Weak transcription	Osteobl	bone

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links